2026年9月29日 / 美国东部时间下午4:03 / 哥伦比亚广播公司新闻
作者：雅各布·罗森
雅各布·罗森是司法部记者。杰克·罗森是负责报道司法部的记者，此前曾担任竞选数字记者，报道特朗普总统2024年竞选活动，还曾担任《与玛格丽特·布伦南面对全国》节目的助理制片人。
阅读完整简历
根据周二公开的法庭文件，两名印度国民因涉嫌参与向美国分销商销售假冒奥司他韦的国际骗局，被控共谋和走私罪。
现年33岁的斯瓦纳迪普·罗伊和37岁的维基·拉曼查均为迪拜居民、印度公民，他们于2025年在佛罗里达中区被起诉，被控以折扣价格向美国分销商走私假冒奥司他韦。
罗伊和拉曼查据称从中国未经授权的制造商处走私并向美国销售了数千剂这款热门减肥药，绕过了由美国食品药品监督管理局监管的高度规范的批发分销市场。
罗伊从意大利被引渡到美国后，于周二在联邦法院首次出庭。拉曼查目前仍在逃。
罗伊和拉曼查被控一项共谋走私和欺诈美国罪、三项走私罪，以及两项销售假药和持有假药待售罪。如果定罪，两人每项罪名最高可判处71年监禁。
美国司法部在起诉书中称，该骗局始于2023年7月，一直持续到2024年4月。法庭文件显示，这些假药带有伪造的包装、说明书、标签和针头，旨在让消费者误以为购买的是丹麦制药公司诺和诺德生产的正品奥司他韦。2023年12月，美国食品药品监督管理局向消费者发出警告，称美国供应链中出现了假冒奥司他韦。
这些假冒药品以折扣价格卖给美国分销商，再由分销商转卖给消费者。美国食品药品监督管理局警告称，危险假药数量呈上升趋势，对健康构成严重风险。美国食品药品监督管理局要求GLP-1类药物必须凭处方购买。
blob:https://www.cbsnews.com/5d881994-61a7-45a0-be2a-7d143b548cf0
根据起诉书，这两人据称怂恿企业无视合规顾虑，曾在一条信息中写道：“如果你想要便宜的产品，就必须明白有人会偷工减料。”检察官还称，这两人威胁过参与分销骗局的相关人员。
2024年3月，拉曼查据称协助将约11000剂假药运送到俄亥俄州的一个仓库。在其他案件中，数千剂药品被销售或分销给佛罗里达州的企业。
美国司法部刑事司助理部长A.泰森·杜瓦在一份声明中表示：“假冒处方药——尤其是常用药——威胁着每一位依赖药品供应链诚信的美国人的健康和安全。这些被告据称为了牟利而牺牲民众的健康。我们将继续追查任何试图用假药欺骗美国消费者的人。”
罗伊的律师在周二的庭审和针对其当事人的指控上拒绝置评。
2 indicted in connection with counterfeit Ozempic scheme in Florida
September 29, 2026 / 4:03 PM EDT / CBS News
By Jacob Rosen
Jacob Rosen is a Justice Department Reporter. Jake Rosen is a reporter covering the Department of Justice. He was previously a campaign digital reporter covering President Trump’s 2024 campaign and also served as an associate producer for “Face the Nation with Margaret Brennan.”
Read Full Bio
Two Indian nationals have been indicted on conspiracy and smuggling charges related to an international scheme to sell counterfeit Ozempic to U.S. distributors, according to court filings unsealed on Tuesday.
Swapnadip Roy, 33, and Vicky Ramancha, 37, who are both residents of Dubai and Indian citizens, were indicted in the Middle District of Florida in 2025 for allegedly smuggling counterfeit Ozempic to distributors in the United States at discounted prices.
Roy and Ramancha allegedly smuggled and sold thousands of counterfeit units of the popular weight-loss drug into the U.S. from unauthorized manufacturers in China, subverting the highly regulated wholesale distribution market in the U.S. that is overseen by the Food and Drug Administration.
Roy made his initial appearance in federal court on Tuesday after being extradited from Italy to the U.S. Ramancha is still at large.
Roy and Ramancha are charged with one count of conspiracy to commit smuggling and to defraud the U.S., three counts of smuggling, and two counts of selling counterfeit drugs and holding counterfeit drugs for sale. If convicted, they each face a maximum penalty of 71 years in prison.
The scheme began in July 2023 and continued through April 2024, the Justice Department alleged in the indictment. According to court documents the counterfeit drugs had fake packaging, inserts, labels and needles, all meant to convince individual customers they were purchasing authorized Ozempic, which is manufactured by the Danish pharmaceutical company Novo Nordisk. In December 2023, the FDA warned consumers that a counterfeit version of Ozempic had appeared in the U.S. supply chain.
The counterfeit units were sold to distributors in the U.S. at discounted prices, and from there would be sold to consumers. The FDA has warned that hazardous counterfeits are on the rise and pose serious health risks. The FDA requires a prescription for GLP-1 drugs.
blob:https://www.cbsnews.com/5d881994-61a7-45a0-be2a-7d143b548cf0
According to the indictment, the pair allegedly encouraged companies to ignore compliance concerns, writing in one message that “if you want the product cheap, you have to understand that there are some corners being cut.” Prosecutors also alleged that the pair threatened individuals involved in the distribution scheme.
In March 2024, Ramancha is alleged to have facilitated the delivery of approximately 11,000 units of the fake drug to a warehouse in Ohio. In other instances, thousands of doses were sold or distributed to companies in Florida.
“Counterfeit prescription drugs — especially common ones — threaten the health and safety of every American who depends on the integrity of our pharmaceutical supply,” Assistant Attorney General A. Tysen Duva of the Justice Department’s Criminal Division said in a statement. “These defendants allegedly exploited people’s health to pay themselves. We will keep pursuing anyone who seeks to deceive American consumers with counterfeit drugs.”
Lawyers for Roy declined to comment on Tuesday’s proceedings and the charges against their client.
发表回复